Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy.
Navarro F, Casares N, Martín-Otal C, Lasarte-Cía A, Gorraiz M, Sarrión P, Llopiz D, Reparaz D, Varo N, Rodriguez-Madoz JR, Prosper F, Hervás-Stubbs S, Lozano T, Lasarte JJ. Navarro F, et al. Among authors: reparaz d. Oncoimmunology. 2022 May 1;11(1):2070337. doi: 10.1080/2162402X.2022.2070337. eCollection 2022. Oncoimmunology. 2022. PMID: 35529677 Free PMC article.
When Cancer Vaccines Go Viral.
Repáraz D, Llopiz D, Sarobe P. Repáraz D, et al. Clin Cancer Res. 2019 Aug 15;25(16):4871-4873. doi: 10.1158/1078-0432.CCR-19-1652. Epub 2019 Jun 21. Clin Cancer Res. 2019. PMID: 31227502
Neoantigens as potential vaccines in hepatocellular carcinoma.
Repáraz D, Ruiz M, Llopiz D, Silva L, Vercher E, Aparicio B, Egea J, Tamayo-Uria I, Hervás-Stubbs S, García-Balduz J, Castro C, Iñarrairaegui M, Tagliamonte M, Mauriello A, Cavalluzzo B, Buonaguro L, Rohrer C, Heim K, Tauber C, Hofmann M, Thimme R, Sangro B, Sarobe P. Repáraz D, et al. J Immunother Cancer. 2022 Feb;10(2):e003978. doi: 10.1136/jitc-2021-003978. J Immunother Cancer. 2022. PMID: 35193931 Free PMC article.
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting Glypican 3 effectively control human hepatocellular carcinoma in mice.
Vercher E, Covo-Vergara Á, Conde E, Hernández-Rueda M, Elizalde E, Mancheño U, Glez-Vaz J, Tamayo-Uria I, García-García MR, Ferrer-Roig M, Marañón-Lopez J, Repáraz D, Ruiz M, López-Díaz de Cerio A, Inogés S, Iñarrairaegui M, Lasarte JJ, Sangro B, Sarobe P, Hervas-Stubbs S. Vercher E, et al. Among authors: reparaz d. Hepatology. 2024 Nov 26. doi: 10.1097/HEP.0000000000001175. Online ahead of print. Hepatology. 2024. PMID: 39601444
13 results